PDVAC Executive summary 2020: Full Value of Vaccine Assessment (FVVA) for Shigella vaccines

Overview

2020 WHO Product Development for Vaccines Advisory Committee (PDVAC) Virtual Consultation 3: Full Value of Vaccine Assessment (FVVA) for Shigella vaccines: 18 May 2020

This session is to discuss the critical questions that could inform the assessment from the PDVAC perspective, the
relative importance of those critical questions, and to identify gaps or other questions that should also be considered.